Efficacy and safety of sublingual immunotherapy in Asian children

Il Ho Park, Sung Moon Hong, Heung Man Lee

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objective: Sublingual immunotherapy is currently accepted as a suitable alternative to subcutaneous immunotherapy because of its easy and painless administration and improved safety. Many clinical trials have demonstrated that sublingual immunotherapy is an effective and safe treatment for pollen or mite allergic rhinitis. However, there have been very few studies overall on children with allergic rhinitis who are sensitized to house-dust mites in Asia. The purpose of the present study was to investigate the efficacy and safety of sublingual immunotherapy in children with allergic rhinitis to house-dust mites. Methods: A total of 112 patients under the age of 15 who had allergic rhinitis to Dermatophagoides pteronyssinus and Dermatophagoides farinae were included. All patients were treated with sublingual immunotherapy (Staloral®). Symptom scores and quality of life were evaluated by questionnaires until one year after sublingual immunotherapy. The medication score was assessed monthly using a diary medication card and serologic tests were evaluated before and 6 and 12months after treatment. Adverse effects and compliance were also investigated. Results: All nasal and non-nasal symptoms and quality of life were significantly improved after treatment. The total medication score was decreased significantly after sublingual immunotherapy. There was no significant change in serologic tests. Some minor adverse effects were reported, however there were no systemic reactions. The drop-out rate was 21%. Conclusions: Sublingual immunotherapy is a valuable therapy for the treatment of allergic rhinitis in Asian children sensitized to house-dust mites.

Original languageEnglish
Pages (from-to)1761-1766
Number of pages6
JournalInternational Journal of Pediatric Otorhinolaryngology
Volume76
Issue number12
DOIs
Publication statusPublished - 2012 Dec 1

Fingerprint

Sublingual Immunotherapy
Safety
Pyroglyphidae
Serologic Tests
Quality of Life
Dermatophagoides farinae
Dermatophagoides pteronyssinus
Therapeutics
Mites
Pollen
Nose
Immunotherapy
Compliance
Allergic Rhinitis
Clinical Trials

Keywords

  • Allergic rhinitis
  • Children
  • Immunotherapy

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Pediatrics, Perinatology, and Child Health

Cite this

Efficacy and safety of sublingual immunotherapy in Asian children. / Park, Il Ho; Hong, Sung Moon; Lee, Heung Man.

In: International Journal of Pediatric Otorhinolaryngology, Vol. 76, No. 12, 01.12.2012, p. 1761-1766.

Research output: Contribution to journalArticle

@article{a3cd2a746a954c51b6353180f2a834f1,
title = "Efficacy and safety of sublingual immunotherapy in Asian children",
abstract = "Objective: Sublingual immunotherapy is currently accepted as a suitable alternative to subcutaneous immunotherapy because of its easy and painless administration and improved safety. Many clinical trials have demonstrated that sublingual immunotherapy is an effective and safe treatment for pollen or mite allergic rhinitis. However, there have been very few studies overall on children with allergic rhinitis who are sensitized to house-dust mites in Asia. The purpose of the present study was to investigate the efficacy and safety of sublingual immunotherapy in children with allergic rhinitis to house-dust mites. Methods: A total of 112 patients under the age of 15 who had allergic rhinitis to Dermatophagoides pteronyssinus and Dermatophagoides farinae were included. All patients were treated with sublingual immunotherapy (Staloral{\circledR}). Symptom scores and quality of life were evaluated by questionnaires until one year after sublingual immunotherapy. The medication score was assessed monthly using a diary medication card and serologic tests were evaluated before and 6 and 12months after treatment. Adverse effects and compliance were also investigated. Results: All nasal and non-nasal symptoms and quality of life were significantly improved after treatment. The total medication score was decreased significantly after sublingual immunotherapy. There was no significant change in serologic tests. Some minor adverse effects were reported, however there were no systemic reactions. The drop-out rate was 21{\%}. Conclusions: Sublingual immunotherapy is a valuable therapy for the treatment of allergic rhinitis in Asian children sensitized to house-dust mites.",
keywords = "Allergic rhinitis, Children, Immunotherapy",
author = "Park, {Il Ho} and Hong, {Sung Moon} and Lee, {Heung Man}",
year = "2012",
month = "12",
day = "1",
doi = "10.1016/j.ijporl.2012.08.017",
language = "English",
volume = "76",
pages = "1761--1766",
journal = "International Journal of Pediatric Otorhinolaryngology",
issn = "0165-5876",
publisher = "Elsevier Ireland Ltd",
number = "12",

}

TY - JOUR

T1 - Efficacy and safety of sublingual immunotherapy in Asian children

AU - Park, Il Ho

AU - Hong, Sung Moon

AU - Lee, Heung Man

PY - 2012/12/1

Y1 - 2012/12/1

N2 - Objective: Sublingual immunotherapy is currently accepted as a suitable alternative to subcutaneous immunotherapy because of its easy and painless administration and improved safety. Many clinical trials have demonstrated that sublingual immunotherapy is an effective and safe treatment for pollen or mite allergic rhinitis. However, there have been very few studies overall on children with allergic rhinitis who are sensitized to house-dust mites in Asia. The purpose of the present study was to investigate the efficacy and safety of sublingual immunotherapy in children with allergic rhinitis to house-dust mites. Methods: A total of 112 patients under the age of 15 who had allergic rhinitis to Dermatophagoides pteronyssinus and Dermatophagoides farinae were included. All patients were treated with sublingual immunotherapy (Staloral®). Symptom scores and quality of life were evaluated by questionnaires until one year after sublingual immunotherapy. The medication score was assessed monthly using a diary medication card and serologic tests were evaluated before and 6 and 12months after treatment. Adverse effects and compliance were also investigated. Results: All nasal and non-nasal symptoms and quality of life were significantly improved after treatment. The total medication score was decreased significantly after sublingual immunotherapy. There was no significant change in serologic tests. Some minor adverse effects were reported, however there were no systemic reactions. The drop-out rate was 21%. Conclusions: Sublingual immunotherapy is a valuable therapy for the treatment of allergic rhinitis in Asian children sensitized to house-dust mites.

AB - Objective: Sublingual immunotherapy is currently accepted as a suitable alternative to subcutaneous immunotherapy because of its easy and painless administration and improved safety. Many clinical trials have demonstrated that sublingual immunotherapy is an effective and safe treatment for pollen or mite allergic rhinitis. However, there have been very few studies overall on children with allergic rhinitis who are sensitized to house-dust mites in Asia. The purpose of the present study was to investigate the efficacy and safety of sublingual immunotherapy in children with allergic rhinitis to house-dust mites. Methods: A total of 112 patients under the age of 15 who had allergic rhinitis to Dermatophagoides pteronyssinus and Dermatophagoides farinae were included. All patients were treated with sublingual immunotherapy (Staloral®). Symptom scores and quality of life were evaluated by questionnaires until one year after sublingual immunotherapy. The medication score was assessed monthly using a diary medication card and serologic tests were evaluated before and 6 and 12months after treatment. Adverse effects and compliance were also investigated. Results: All nasal and non-nasal symptoms and quality of life were significantly improved after treatment. The total medication score was decreased significantly after sublingual immunotherapy. There was no significant change in serologic tests. Some minor adverse effects were reported, however there were no systemic reactions. The drop-out rate was 21%. Conclusions: Sublingual immunotherapy is a valuable therapy for the treatment of allergic rhinitis in Asian children sensitized to house-dust mites.

KW - Allergic rhinitis

KW - Children

KW - Immunotherapy

UR - http://www.scopus.com/inward/record.url?scp=84869125205&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869125205&partnerID=8YFLogxK

U2 - 10.1016/j.ijporl.2012.08.017

DO - 10.1016/j.ijporl.2012.08.017

M3 - Article

VL - 76

SP - 1761

EP - 1766

JO - International Journal of Pediatric Otorhinolaryngology

JF - International Journal of Pediatric Otorhinolaryngology

SN - 0165-5876

IS - 12

ER -